Latest News & Features
Biotechnology
The English Court of Appeal has reversed a finding that two of Regeneron’s European patents covering transgenic mice were insufficient. 29 March 2018
Americas
A US judge has overturned a jury verdict which found that Teva owed GSK $235 million in damages for infringing a patent covering a blood pressure drug. 29 March 2018
Americas
A Delaware court has dismissed a patent infringement claim brought by Amgen against a biosimilar maker. 28 March 2018
Big Pharma
GSK has revealed that it will buy Novartis out of their joint consumer healthcare business. 27 March 2018
Americas
A US judge handed a win to Shire late last week, finding that a generic version of its attention deficit hyperactivity disorder drug Adderall XR would infringe Shire’s patents. 27 March 2018
Europe
The English High Court has rejected molecular diagnostics company Premaitha Health’s attempt to stop a patent infringement claim. 26 March 2018
Americas
UK-based Indivior has pledged to appeal a US court decision that found a drug developed by generics maker Alvogen doesn’t infringe three of Indivior’s patents. 26 March 2018
Americas
Novartis and Harvard University have teamed up to develop Harvard’s proprietary biomaterial systems to deliver cancer immunotherapies. 23 March 2018
Americas
Novartis has accused competitor Regeneron of patent infringement through the latter’s sale of Eylea and Zaltrap. 22 March 2018
Europe
Late-filed documents will come under greater scrutiny in light of changes to the European Patent Office’s opposition procedure. 22 March 2018